Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IceCure Medical (ICCM) Invested Capital (2020 - 2025)

Historic Invested Capital for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $9.3 million.

  • IceCure Medical's Invested Capital fell 749.5% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 749.5%. This contributed to the annual value of $6.9 million for FY2024, which is 4326.24% down from last year.
  • Per IceCure Medical's latest filing, its Invested Capital stood at $9.3 million for Q3 2025, which was down 749.5% from $2.9 million recorded in Q2 2025.
  • Over the past 5 years, IceCure Medical's Invested Capital peaked at $25.4 billion during Q4 2022, and registered a low of $2.9 million during Q2 2025.
  • For the 5-year period, IceCure Medical's Invested Capital averaged around $1.4 billion, with its median value being $14.3 million (2021).
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 9420224.79% in 2022, then tumbled by 9995.22% in 2023.
  • Over the past 5 years, IceCure Medical's Invested Capital (Quarter) stood at $27.0 million in 2021, then soared by 94202.25% to $25.4 billion in 2022, then plummeted by 99.95% to $12.2 million in 2023, then crashed by 43.26% to $6.9 million in 2024, then skyrocketed by 34.85% to $9.3 million in 2025.
  • Its Invested Capital stands at $9.3 million for Q3 2025, versus $2.9 million for Q2 2025 and $6.0 million for Q1 2025.